Magazine article from our research archive:
|
|
Cut Points for Lipids and Lipoproteins in Children and Adolescents: Should They Be Reassessed?
- Article from:
-
Clinical Chemistry
- Article date:
-
July 1, 2008
- Author:
-
|
Copyright informationCopyright American Association for Clinical Chemistry Jul 2008. Provided by ProQuest LLC. (Hide copyright information)
|
Antecedent plasma concentrations of lipids and Iipoproteins are associated with both early pathologic lesions of atherosclerosis and arterial changes in vivo, such as carotid intima media thickness (IMT)2 and endothelial dysfunction (1, 2). Healthy normolipidemic Finnish children, treated with a low-saturated fat, lowcholesterol diet from the age of 7 months to 11 years, had less carotid IMT than controls. In Dutch children and adolescents with heterozygous familial hypercholesterolemia (FH), treatment for 2 years with a similar diet and an inhibitor of hydroxymethylglutaryl CoA reductase led to decreased carotid IMT compared to IMT in FH children treated with diet and placebo. Impaired ...
Related newspaper, magazine, and journal articles:
|
Teen cholesterol norms to aid CVD risk assessment.(News)
Family Practice News;
September 15, 2006 ;
581 words
......age- and gender-specific growth curves and cut points were developed for total cholesterol, LDL- and...increased-risk values pass through the respective adult cut points at 20 years of age identified by the National...NCEP). In addition, tables listing age-specific cut points for ...
|
|
Age-specific cholesterol guidelines are proposed.(Clinical Rounds;)
Pediatric News;
October 1, 2006 ;
688 words
......age- and gender-specific growth curves and cut points were developed for total cholesterol, LDL- and...increased-risk values pass through the respective adult cut points at 20 years of age identified by the National...NCEP). In addition, tables listing age-specific cut points for ...
|
|
Letter: Your Say - Pay cut points ; In association with POST OFFICE
Birmingham Mail;
December 20, 2007 ;
99 words
...YOU have had many letters on the subject of public service pay recently and I feel many correspondents are young and have no knowledge of 12-15 years ago. So I make these points. All pay and bonuses are finally agreed by councillors or government and should not be altered without full agreement. It
|
|
European Dyslipidemia Market Showing Significant Growth.
PR Newswire;
March 9, 2005 ;
700+ words
......c13695) has announced the addition of Dyslipidemia: The Expanding Market for Statins and...to die as a result of such diseases. Dyslipidemia, involving levels of cholesterol and...these statistics and the role played by dyslipidemia in CVD, action is being taken to monitor...
|
|
Comorbid dyslipidemia and HT have high price.(Cardiovascular...
Family Practice News;
June 15, 2005 ;
365 words
......uncontrolled comorbid hypertension and dyslipidemia, and an estimated 1 in 10 of these...uncontrolled comorbid hypertension and dyslipidemia, he added. His Pfizer-supported study...of Americans with hypertension have dyslipidemia as well. Moreover, an estimated 17...
|
|
Effect of Gene Polymorphisms on Lipoprotein Levels in Patients with...
Physiological Research;
September 1, 2006 ;
700+ words
...Summary Dyslipidemia in the metabolic syndrome (MS) is...The pathogenesis of this type of dyslipidemia is partially explained, but its genetic...gene polymorphism on lipid levels in dyslipidemia of the metabolic syndrome, 150 patients...
|
|
Research and Markets - Dyslipidemia: The Expanding Market for Statins and...
M2 Presswire;
November 29, 2004 ;
700+ words
......and Markets: Research and Markets - Dyslipidemia: The Expanding Market for Statins and...c10234) has announced the addition of Dyslipidemia: The Expanding Market for Statins and...Management Products to their offering Dyslipidemia, involving levels of cholesterol and...
|
|
Dyslipidemia - Statins Dominate Treatment Pathway - For Now.
M2 Presswire;
November 22, 2005 ;
487 words
......November 2005-Research and Markets: Dyslipidemia - Statins Dominate Treatment Pathway...c28248) has announced the addition of Dyslipidemia - Statins Dominate Treatment Pathway...companies to target the under-treated dyslipidemia sub-populations. This report includes180...
|
|
Effect of Serum Gamma-Glutamyltransferase and Obesity on the Risk of...
Clinical Chemistry;
October 1, 2007 ;
700+ words
......association of BMI with hypertension, dyslipidemia, and poor glycemic control differed...treatment, and to have atherogenic dyslipidemia if they had high triglycerides (>...interaction relationships with hypertension, dyslipidemia, or glycemic control as the dependent...
|
|
Combination Diet and Exercise Interventions for the Treatment of...
The Journal of Nutrition;
August 1, 2005 ;
700+ words
...ABSTRACT At present, dyslipidemia is most commonly treated with...exercise, in the treatment of dyslipidemia. Combination therapies are particularly...levels in those diagnosed with dyslipidemia, and should be implemented in...
|
|
Update on dyslipidemia management: Emerging CHD risk factors, new evidence...
Formulary;
June 1, 2001 ;
700+ words
......of various lipid-lowering therapies, dyslipidemia continues to be widely undertreated...have also influenced the treatment of dyslipidemia. By becoming familiar with treatment...improve the management of patients with dyslipidemia. (Formulary 2001;36:438-60.) oronary...
|
|
Niacin as a component of combination therapy for dyslipidemia
Mayo Clinic Proceedings;
June 1, 2003 ;
700+ words
...Dyslipidemia is one of the most important modifiable risk factors...Niacin has been known to be an effective treatment of dyslipidemia for almost half a century. Niacin substantially increases...offers an important treatment option for patients with dyslipidemia. In particular, niacin complements ...
|
|
Decision Resources and PharMetrics Announce the Availability of First...
PR Newswire;
April 6, 2005 ;
648 words
......availability of DecisionMETRICS -- Dyslipidemia. DecisionMETRICS is a powerful new...significant opportunity to grow the dyslipidemia market, given the large percentage...only 40 of the U.S. population with dyslipidemia is diagnosed. The youngest age-group...
|
|
Surface Logix Starts Phase 2a Clinical Trial of SLx-4090 in Dyslipidemia.
PR Newswire;
June 6, 2007 ;
682 words
......trial of SLx-4090 in patients with dyslipidemia (abnormal levels of lipids in the bloodstream...being developed for the treatment of dyslipidemia. This study builds on the positive...study that will enroll 24 patients with dyslipidemia (high cholesterol and triglyceride...
|
See all results.
Or, try our
Advanced Search.
|